The Supreme Court extends a temporary order maintaining mail access to the abortion pill mifepristone while reviewing a case that could limit its availability nationwide.
Posts tagged as “the Guttmacher Institute”
The Society of Family Planning's report reveals that medication abortions provided by virtual-only providers have increased by 136% since the Supreme Court eliminated the constitutional right to abortion in June 2022. Total abortions decreased by 2%, and the Guttmacher Institute found that medication abortions already accounted for more than half of all US abortions in 2020. The 5th U.S. Circuit Court of Appeals recently ruled to preserve but narrow access to an abortion pill across the U.S., and the rate of medication abortions is likely to continue to rise.
A federal judge has issued an injunction suspending the Food and Drug Administration's (FDA) approval of the abortion pill mifepristone, potentially impacting access to medication abortions nationwide. U.S. District Judge Matthew Kacsmaryk ruled that the FDA's two-decade-old approval of the drug violated a federal rule and was unlawful. The government has a week to appeal the decision, which could have far-reaching implications for abortion access in the United States.
20 Democratic governors have joined forces to form the Reproductive Freedom Alliance in response to the Supreme Court's June ruling which overturned the right to abortion and gave states broad regulatory authority. 44 states have placed some restrictions on or outright banned abortion, making it more difficult for women to access services. The alliance is a step towards protecting and expanding access to abortion services, sending a clear message that the governors are committed to protecting the right to choose.